eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
eXinvest of Emirates and Finchemo Thank Partners for a Year of Growth and Look Ahead to 2026 Expansion in the GCC
Hello dear partners, clients, and friends.
As we approach the end of the year, I want to take a moment to sincerely thank you all for your continued trust and support. It's been a very hard, yet rewarding year for both eXinvest of Emirates and Finchemo. Our main focus has been on internationalization and breaking into new markets, a journey that wouldn't be possible without you.
Looking ahead to 2026, our goal is to become even more connected with the GCC Region. To achieve this, we've invested again in a new holding company. This will strengthen eXinvest's activities and create powerful synergies between the GCC and Europe, by hibryd partecipated company by Finchemo.
I personally want to thank you for standing with us during this delicate and important year. From all of us here, I wish you and your families a lovely and peaceful Christmas. Thank you.
Paolo Antonio Balossi President @ eXinvest of Emirates Founder+President @ Finchemo Holding
Latest
-
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors
-
25. October 2025API Industry Set to Reach $198 Billion by 2030: eXinvest of Emirates Strengthens Its Market Position
-
13. February 2026WHX 2026 Highlights UAE as a Global Hub for Healthcare and Pharmaceuticals: eXinvest and Finchemo Engage with Industry Leaders
-
23. January 2026Finchemo Launches New Website and Operational Phase, Driving Investments in Innovative Healthcare and Pharma Companies
-
26. December 2025Europe Remains the Leading Source of Pharmaceuticals for Global Export: eXinvest of Emirates Leverages Strategic Partnerships
-
20. December 2025eXinvest of Emirates Supports Pharma & Biotech with Comprehensive Outsourced Drug Discovery Services
-
15. December 2025eXinvest of Emirates Delivers Tailor-Made Clean Rooms Across Medical, Pharmaceutical, and Industrial Sectors
-
25. October 2025API Industry Set to Reach $198 Billion by 2030: eXinvest of Emirates Strengthens Its Market Position